Search clinical trials for: Suboxone

Total 105 results

University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Remote Observed Dosing of Suboxone to Improve Clinical Practice

Opioid Dependence | Opioid-use Disorder | Opiate Dependence

United States
Indivior Inc.

Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder | Opioid-related Disorders

United States
Indivior Inc.

Completed

Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") (RIME)

Opioid Dependency

France
Indivior Inc.
Taipei City Psychiatric Center, Taiwan

Completed

Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan

Opiate Dependence

Taiwan
University College, London
University College London Hospitals

Completed

Investigation Into the Role of GTN & RIPC in Cardiac Surgery (ERIC-GTN)

Myocardial Reperfusion Injury

United Kingdom
Children's Mercy Hospital Kansas City

Terminated

Comparison Trial of Enema vs. PEG 3350 for Constipation

Constipation

United States
Wake Forest University Health Sciences

Withdrawn

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Opioid Use
Temple University

Completed

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Colon Cancer

United States
Bayer

Completed

Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)

Constipation

Ireland
Indivior Inc.

Completed

Transfer of Subjects From Subutex/Suboxone to RBP-6300

Opioid Related Disorder

Austria, Czech Republic, Germany, Sweden
ColonaryConcepts LLC

Completed

Safety and Tolerability Study of an Edible Colon Preparation

Bowel Preparation

United States
British Columbia Cancer Agency

Terminated

Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

Cancer | Constipation

Canada
Ohio State University

Withdrawn

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)
Beth Israel Medical Center

Unknown

Sublingual Buprenorphine for Chronic Pain

Chronic Pain

United States
Georgetown University
National Institute on Drug Abuse (NIDA)

Terminated

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Pain | Buprenorphine

United States
Yale University
United States Department of Defense

Completed

Buprenorphine Treatment for Opioid Dependence

Opioid Dependence

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals (Detox)

Opioid Dependence | Opioid Withdrawal | Opioid Detoxification

United States
Yale University
National Institute on Drug Abuse (NIDA); Howard University; George Mason University

Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

Acquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence

United States
Johns Hopkins University

Completed

Assessing the Safety of Buprenorphine in People With Sickle Cell Disease

Sickle Cell Disease

United States
Jordan F. Karp
National Institute of Mental Health (NIMH)

Completed

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine (IRLGREY-B)

Depression | Major Depressive Disorder

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study (MOMs-INO)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome | Drug Abuse in Pregnancy

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

Buprenorphine for Treatment Resistant Depression (BUP-TRD)

Depressive Disorder | Depression | Depressive Disorder, Major

United States
University of California, Los Angeles

Completed

Optimizing Outcomes Using Suboxone for Opiate Dependence (OpBup)

Opioid Dependency

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
NanoSHIFT LLC

Completed

Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone

Healthy

United States
Royal Victoria Hospital, Canada

Not yet recruiting

Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder (STOPIT)

Moderate to Severe Opioid Use Disorder

Canada
Massachusetts General Hospital

Not yet recruiting

Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients

Post-operative Pain

United States
Indivior Inc.

Completed

Single Ascending Dose Study of RBP-6000 (SAD)

Opioid Use Disorder

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study (MOMs-CMA)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain (1401)

Chronic Pain | Opioid-Related Disorders

United States
Butler Hospital

Completed

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Opioid Addiction

United States
Vertex Pharmaceuticals Incorporated
Tibotec BVBA

Completed

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Hepatitis C | Opioid-Related Disorders

United States
University of British Columbia

Recruiting

Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

Opioid-use Disorder

Canada
State University of New York at Buffalo

Terminated

Buprenorphine as a Treatment in Opiate Dependent Pain Patients

Opiate Addiction | Refractory Pain

United States
Duke University

Completed

Providing Suboxone and PrEP Using Telemedicine

Hiv | Opioid Use | Opioid-use Disorder | Risk Reduction

United States
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
NYU Langone Health
Emergency Medicine Foundation

Completed

Buprenorphine Loading in the Emergency Department

Opioid-use Disorder

United States
Maimonides Medical Center

Terminated

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Howard University; George Mason University

Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE)

Acquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
Indivior Inc.

Completed

Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)

Opioid-Related Disorders | Drug Abuse | Opiate Dependence

Austria
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
VA Office of Research and Development

Terminated

Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain (Bup)

Pain

United States
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
Titan Pharmaceuticals
National Institute on Drug Abuse (NIDA)

Completed

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

Opioid Dependency

United States
Massachusetts General Hospital

Not yet recruiting

A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Opioid-use Disorder | Opioid Use Disorder, Mild
Orexo AB
Worldwide Clinical Trials

Completed

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults (ISTART)

Opioid Dependence, on Agonist Therapy

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Maternal Buprenorphine-naloxone Treatment and the Infant

Maternal Opioid Use Disorder | Opioid Exposed Infant

United States

Search clinical trials for: Suboxone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations